Search

Your search keyword '"H Hu"' showing total 289 results

Search Constraints

Start Over You searched for: Author "H Hu" Remove constraint Author: "H Hu" Publisher elsevier bv Remove constraint Publisher: elsevier bv
289 results on '"H Hu"'

Search Results

2. Association between lifestyle-related, psychosocial factors and obesity among female adolescents in Taiwan

6. A comparative life cycle assessment of toothpaste cream versus toothpaste tablets

14. A Comparative Analysis of 150 Thumb Polydactyly Cases from the CoULD Registry Using the Wassel-Flatt, Rotterdam, and Chung Classifications

15. Grand Challenges in global eye health: a global prioritisation process using Delphi method

16. Comparison of 2D BLADE Turbo Gradient- and Spin-Echo and 2D Spin-Echo Echo-Planar Diffusion-Weighted Brain MRI at 3 T: Preliminary Experience in Children

20. Food waste and soybean curd residue composting by black soldier fly

23. 272TiP HARMONIA SOLTI-2101 / AFT-58: A head-to-head phase III study comparing ribociclib (RIB) and palbociclib (PAL) in patients (pts) with hormone receptor-positive/HER2-negative/HER2-enriched (HR+/HER2-/HER2-E) advanced breast cancer (ABC)

24. Crowder-Induced Conformational Ensemble Shift in Escherichia coli Prolyl-tRNA Synthetase

25. Recent Advances in Pediatric Brain, Spine, and Neuromuscular Magnetic Resonance Imaging Techniques

26. 3D T1-weighted contrast-enhanced brain MRI in children using a fat-suppressed golden angle radial acquisition: an alternative to Cartesian inversion-recovery imaging

27. Quantitative MRI assessment of mucinous rectal adenocarcinoma to predict tumour response after neoadjuvant therapy

28. Rotational dynamics of tidally deformed planetary bodies and validity of fluid limit and quasi-fluid approximation

29. 24-epibrassinolide alleviate drought-induced photoinhibition in Capsicum annuum via up-regulation of AOX pathway

34. 309P Antineoplastic (ANP) therapies (Tx) after alpelisib (ALP) or placebo (PBO) + fulvestrant (FUL) in patients (Pts) with hormone receptor-positive (HR+), human epidermal growth factor receptor 2-negative (HER2–), PIK3CA-mutated (Mut) advanced breast cancer (ABC): An analysis from SOLAR-1

35. Spatiotemporal Co-Dependency between Macrophages and Exhausted CD8 + T Cells in Cancer

38. Registered nurses’ knowledge of medical care for older adults with diabetes in long-term care facilities in Taiwan

39. A Signal in the Noise: Noninvasive Acoustical Evaluation of Continuous Flow Left Ventricular Assist Device

40. P56.03 Prognostic Value of Tumor Spread Through Air Spaces in Patients With Lung Adenocarcinoma after Radical Surgery

41. 233P Association of quality of life (QOL) with overall survival (OS) in patients (pts) with HR+/HER2− advanced breast cancer (ABC) treated with ribociclib (RIB) + endocrine therapy (ET) in the MONALEESA-3 (ML-3) and ML-7 trials

42. 511TiP A phase III, multicenter, open-label, randomized study to assess the efficacy and safety of cetuximab plus capecitabine versus cetuximab as maintenance treatment following first-line induction treatment with FOLFOX and cetuximab in Chinese patients with RAS and BRAF WT mCRC

43. Body composition alteration and inflammation are independent predictors of survival in lung cancer patients treated with anlotinib

44. Amélioration sous filgotinib [FIL] des symptômes (douleur, fatigue, état fonctionnel et qualité de vie) rapportés par les patients atteints de polyarthrite rhumatoïde [PR] avec une réponse inadéquate au méthotrexate (MTX-IR) : résultats de l’étude FINCH 1

45. Quantitative Deformability Cytometry: Rapid, Calibrated Measurements of Cell Mechanical Properties

46. Comparison of 2D single-shot turbo-spin-echo and spin-echo echo-planar diffusion weighted brain MRI at 3.0 Tesla: preliminary experience in children

47. Carbon footprint assessment of recycling technologies for rare earth elements: A case study of recycling yttrium and europium from phosphor

48. YAP-dependent mechanotransduction is required for proliferation and migration on native-like substrate topography

49. 329P Ribociclib (RIB) in patients (pts) with HR+/HER2− advanced breast cancer (ABC) and resistance to prior endocrine therapy (ET) in the MONALEESA (ML) -3 and -7 trials

50. 330P Comparative effectiveness of ribociclib plus fulvestrant (RIB+FUL) versus palbociclib plus letrozole (PAL+LET) as first-line (1L) treatment (Tx) of HR+/HER2− advanced breast cancer (ABC) assessed by matching-adjusted indirect comparison (MAIC)

Catalog

Books, media, physical & digital resources